postpartum%20hemorrhage
POSTPARTUM HEMORRHAGE
Postpartum hemorrhage is defined as blood loss of ≥500 mL for vaginal delivery or 1000 mL for abdominal (Caesarean) delivery after completion of the 3rd stage of labor.
Another proposed definition is a 10% fall in hematocrit value.
Since the clinical estimation of the amount of blood loss is typically inaccurate, the diagnosis of postpartum hemorrhage remains a subjective clinical assessment of the amount of blood loss that jeopardizes a woman's hemodynamic stability.
Postpartum hemorrhage may produce hemodynamic instability during the 1st 24 hours after delivery.

Monitoring

Monitor Response to Treatment

  • Sensorium
  • Vital signs
  • Urine output
    • A urine output of >30 mL/hr is an objective sign of adequate renal perfusion
  • Complete blood count (CBC), coagulation
    • Blood sample is drawn to assess hematologic and metabolic profile, electrolytes, coagulation, acid-base oxygenation status
  • Evaluate tissue perfusion
    • Measure serum lactate and base deficit 
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 06 Apr 2018

A better quality of diet during pregnancy is associated with lower neonatal adiposity and longer infant length at birth, according to findings from the GUSTO* study.

07 Apr 2018
Female cyclists do not have significantly worse urinary or sexual function compared with other athletes, a recent study has shown. However, other genitourinary conditions, such as saddle sores and genital numbness, are associated with cycling and may lead to sexual dysfunction.
26 Feb 2017
Placement of cervical pessary in women with short cervices and singleton pregnancies does not lower the risk of having preterm births, according to the results of a meta-analysis.
Pearl Toh, 07 Apr 2018
Managing asthma with short-acting β-agonists (SABAs) was associated with reduced fertility in women, while the use of inhaled corticosteroids (ICS) with or without long-acting β-agonists (LABAs) was not, according to the SCOPE* study.